Dolasetron mesylate oral
Full descriptor
Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Details
- Code
- Q0180
- Short descriptor
- Dolasetron mesylate oral
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Apr 1 1998
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Unspecified oral anti-emetic
Hydroxyzine pamoate 25mg
Perphenazine 4mg oral
Trimethobenzamide hcl 250mg
Promethazine hcl 12.5mg oral
Dronabinol 2.5mg oral
Granisetron hcl 1 mg oral
Prochlorperazine maleate 5mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.